| View web version.
|
 |
| |
| The volume of data presented at a conference is challenging for oncologists to consume in real time. We have a solution to ensure your leading abstracts and sessions remain top of mind and live as enduring educational content. |
| |
| Rapid Readouts are an exciting way of showcasing critical information to be sure nothing is missed. In each segment, leading experts will: |
- Review key abstracts/presentations from the latest conferences
- Provide academic and community audiences with a timely look at data vital to improving patient care
|
| |
| |
| Experience a Rapid Readout Today! |
 |
| Phase 1/2 Study Results of Liposomal Irinotecan and FOLFOX |
| Zev A. Wainberg, MD, reviews the results from the phase 1/2 study of liposomal irinotecan + 5 fluorouracil/leucovorin + oxaliplatin in patients with pancreatic ductal adenocarcinoma. |
| |
| |
Reach out today so we can discuss your data
and upcoming conferences! |
| |
|
|
